# An Evaluation of the Long-term Safety of Magnesium Iron Hydroxycarbonate

> **NCT00358722** · PHASE2 · TERMINATED · sponsor: **Ineos Healthcare Limited** · enrollment: 44 (actual)

## Conditions studied

- Chronic Kidney Failure

## Interventions

- **DRUG:** Fermagate

## Key facts

- **NCT ID:** NCT00358722
- **Lead sponsor:** Ineos Healthcare Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-07
- **Primary completion:** 2008-05
- **Final completion:** 2008-06
- **Target enrollment:** 44 (ACTUAL)
- **Why stopped:** Limited number of subjects
- **Last updated:** 2009-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00358722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00358722, "An Evaluation of the Long-term Safety of Magnesium Iron Hydroxycarbonate". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00358722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*